Comparing	O
the	O
bulking	O
effect	O
of	O
calcium	B:C0115137
hydroxyapatite	I:C0115137
and	O
Deflux	O
injection	O
into	O
the	O
bladder	O
neck	I:C0227716
for	O
improvement	O
of	O
urinary	O
incontinence	I:C0042024
in	O
bladder	O
exstrophy	I:C1838703
-	I:C1838703
epispadias	I:C1838703
complex	I:C1838703
.	O

Comparing	O
the	O
bulking	O
effect	O
of	O
calcium	O
hydroxyapatite	I:C0115137
and	O
Deflux	B:C0299556
injection	O
into	O
the	O
bladder	O
neck	I:C0227716
for	O
improvement	O
of	O
urinary	O
incontinence	I:C0042024
in	O
bladder	O
exstrophy	I:C1838703
-	I:C1838703
epispadias	I:C1838703
complex	I:C1838703
.	O

Comparing	O
the	O
bulking	O
effect	O
of	O
calcium	O
hydroxyapatite	I:C0115137
and	O
Deflux	O
injection	B:C0021485
into	O
the	O
bladder	O
neck	I:C0227716
for	O
improvement	O
of	O
urinary	O
incontinence	I:C0042024
in	O
bladder	O
exstrophy	I:C1838703
-	I:C1838703
epispadias	I:C1838703
complex	I:C1838703
.	O

Comparing	O
the	O
bulking	O
effect	O
of	O
calcium	O
hydroxyapatite	I:C0115137
and	O
Deflux	O
injection	O
into	O
the	O
bladder	B:C0227716
neck	I:C0227716
for	O
improvement	O
of	O
urinary	O
incontinence	I:C0042024
in	O
bladder	O
exstrophy	I:C1838703
-	I:C1838703
epispadias	I:C1838703
complex	I:C1838703
.	O

Comparing	O
the	O
bulking	O
effect	O
of	O
calcium	O
hydroxyapatite	I:C0115137
and	O
Deflux	O
injection	O
into	O
the	O
bladder	O
neck	I:C0227716
for	O
improvement	O
of	O
urinary	B:C0042024
incontinence	I:C0042024
in	O
bladder	O
exstrophy	I:C1838703
-	I:C1838703
epispadias	I:C1838703
complex	I:C1838703
.	O

Comparing	O
the	O
bulking	O
effect	O
of	O
calcium	O
hydroxyapatite	I:C0115137
and	O
Deflux	O
injection	O
into	O
the	O
bladder	O
neck	I:C0227716
for	O
improvement	O
of	O
urinary	O
incontinence	I:C0042024
in	O
bladder	B:C1838703
exstrophy	I:C1838703
-	I:C1838703
epispadias	I:C1838703
complex	I:C1838703
.	O

The	O
aim	O
of	O
this	O
study	B:C2603343
was	O
to	O
evaluate	O
the	O
efficacy	O
of	O
the	O
endoscopic	O
injection	I:C3522839
of	O
calcium	O
hydroxyapatite	I:C0115137
(	O
calcium	O
hydroxyapatite	I:C0115137
)	O
into	O
the	O
bladder	O
neck	I:C0227716
(	O
bladder	O
neck	I:C0227716
)	O
region	O
of	O
patients	O
with	O
urinary	O
incontinence	I:C0042024
and	O
bladder	O
exstrophy	I:C1838703
-	I:C1838703
epispadias	I:C1838703
complex	I:C1838703
(	O
bladder	O
exstrophy	I:C1838703
-	I:C1838703
epispadias	I:C1838703
complex	I:C1838703
)	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
efficacy	O
of	O
the	O
endoscopic	B:C3522839
injection	I:C3522839
of	O
calcium	O
hydroxyapatite	I:C0115137
(	O
calcium	O
hydroxyapatite	I:C0115137
)	O
into	O
the	O
bladder	O
neck	I:C0227716
(	O
bladder	O
neck	I:C0227716
)	O
region	O
of	O
patients	O
with	O
urinary	O
incontinence	I:C0042024
and	O
bladder	O
exstrophy	I:C1838703
-	I:C1838703
epispadias	I:C1838703
complex	I:C1838703
(	O
bladder	O
exstrophy	I:C1838703
-	I:C1838703
epispadias	I:C1838703
complex	I:C1838703
)	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
efficacy	O
of	O
the	O
endoscopic	O
injection	I:C3522839
of	O
calcium	B:C0115137
hydroxyapatite	I:C0115137
(	O
calcium	O
hydroxyapatite	I:C0115137
)	O
into	O
the	O
bladder	O
neck	I:C0227716
(	O
bladder	O
neck	I:C0227716
)	O
region	O
of	O
patients	O
with	O
urinary	O
incontinence	I:C0042024
and	O
bladder	O
exstrophy	I:C1838703
-	I:C1838703
epispadias	I:C1838703
complex	I:C1838703
(	O
bladder	O
exstrophy	I:C1838703
-	I:C1838703
epispadias	I:C1838703
complex	I:C1838703
)	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
efficacy	O
of	O
the	O
endoscopic	O
injection	I:C3522839
of	O
calcium	O
hydroxyapatite	I:C0115137
(	O
calcium	B:C0115137
hydroxyapatite	I:C0115137
)	O
into	O
the	O
bladder	O
neck	I:C0227716
(	O
bladder	O
neck	I:C0227716
)	O
region	O
of	O
patients	O
with	O
urinary	O
incontinence	I:C0042024
and	O
bladder	O
exstrophy	I:C1838703
-	I:C1838703
epispadias	I:C1838703
complex	I:C1838703
(	O
bladder	O
exstrophy	I:C1838703
-	I:C1838703
epispadias	I:C1838703
complex	I:C1838703
)	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
efficacy	O
of	O
the	O
endoscopic	O
injection	I:C3522839
of	O
calcium	O
hydroxyapatite	I:C0115137
(	O
calcium	O
hydroxyapatite	I:C0115137
)	O
into	O
the	O
bladder	B:C0227716
neck	I:C0227716
(	O
bladder	O
neck	I:C0227716
)	O
region	O
of	O
patients	O
with	O
urinary	O
incontinence	I:C0042024
and	O
bladder	O
exstrophy	I:C1838703
-	I:C1838703
epispadias	I:C1838703
complex	I:C1838703
(	O
bladder	O
exstrophy	I:C1838703
-	I:C1838703
epispadias	I:C1838703
complex	I:C1838703
)	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
efficacy	O
of	O
the	O
endoscopic	O
injection	I:C3522839
of	O
calcium	O
hydroxyapatite	I:C0115137
(	O
calcium	O
hydroxyapatite	I:C0115137
)	O
into	O
the	O
bladder	O
neck	I:C0227716
(	O
bladder	B:C0227716
neck	I:C0227716
)	O
region	O
of	O
patients	O
with	O
urinary	O
incontinence	I:C0042024
and	O
bladder	O
exstrophy	I:C1838703
-	I:C1838703
epispadias	I:C1838703
complex	I:C1838703
(	O
bladder	O
exstrophy	I:C1838703
-	I:C1838703
epispadias	I:C1838703
complex	I:C1838703
)	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
efficacy	O
of	O
the	O
endoscopic	O
injection	I:C3522839
of	O
calcium	O
hydroxyapatite	I:C0115137
(	O
calcium	O
hydroxyapatite	I:C0115137
)	O
into	O
the	O
bladder	O
neck	I:C0227716
(	O
bladder	O
neck	I:C0227716
)	O
region	O
of	O
patients	O
with	O
urinary	B:C0042024
incontinence	I:C0042024
and	O
bladder	O
exstrophy	I:C1838703
-	I:C1838703
epispadias	I:C1838703
complex	I:C1838703
(	O
bladder	O
exstrophy	I:C1838703
-	I:C1838703
epispadias	I:C1838703
complex	I:C1838703
)	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
efficacy	O
of	O
the	O
endoscopic	O
injection	I:C3522839
of	O
calcium	O
hydroxyapatite	I:C0115137
(	O
calcium	O
hydroxyapatite	I:C0115137
)	O
into	O
the	O
bladder	O
neck	I:C0227716
(	O
bladder	O
neck	I:C0227716
)	O
region	O
of	O
patients	O
with	O
urinary	O
incontinence	I:C0042024
and	O
bladder	B:C1838703
exstrophy	I:C1838703
-	I:C1838703
epispadias	I:C1838703
complex	I:C1838703
(	O
bladder	O
exstrophy	I:C1838703
-	I:C1838703
epispadias	I:C1838703
complex	I:C1838703
)	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
efficacy	O
of	O
the	O
endoscopic	O
injection	I:C3522839
of	O
calcium	O
hydroxyapatite	I:C0115137
(	O
calcium	O
hydroxyapatite	I:C0115137
)	O
into	O
the	O
bladder	O
neck	I:C0227716
(	O
bladder	O
neck	I:C0227716
)	O
region	O
of	O
patients	O
with	O
urinary	O
incontinence	I:C0042024
and	O
bladder	O
exstrophy	I:C1838703
-	I:C1838703
epispadias	I:C1838703
complex	I:C1838703
(	O
bladder	B:C1838703
exstrophy	I:C1838703
-	I:C1838703
epispadias	I:C1838703
complex	I:C1838703
)	O
.	O

We	O
designed	O
a	O
retrospective	B:C2985505
cohort	I:C2985505
study	I:C2985505
in	O
which	O
we	O
retrospectively	O
studied	I:C0035363
medical	O
charts	O
of	O
female	O
and	O
male	O
patients	O
of	O
bladder	O
exstrophy	I:C1838703
-	I:C1838703
epispadias	I:C1838703
complex	I:C1838703
who	O
had	O
undergone	O
calcium	O
hydroxyapatite	I:C0115137
or	O
Deflux	O
injection	O
for	O
continence	O
improvement	I:C1536613
between	O
2009	O
and	O
2014	O
.	O

We	O
designed	O
a	O
retrospective	O
cohort	I:C2985505
study	I:C2985505
in	O
which	O
we	O
retrospectively	B:C0035363
studied	I:C0035363
medical	O
charts	O
of	O
female	O
and	O
male	O
patients	O
of	O
bladder	O
exstrophy	I:C1838703
-	I:C1838703
epispadias	I:C1838703
complex	I:C1838703
who	O
had	O
undergone	O
calcium	O
hydroxyapatite	I:C0115137
or	O
Deflux	O
injection	O
for	O
continence	O
improvement	I:C1536613
between	O
2009	O
and	O
2014	O
.	O

We	O
designed	O
a	O
retrospective	O
cohort	I:C2985505
study	I:C2985505
in	O
which	O
we	O
retrospectively	O
studied	I:C0035363
medical	O
charts	O
of	O
female	O
and	O
male	O
patients	O
of	O
bladder	B:C1838703
exstrophy	I:C1838703
-	I:C1838703
epispadias	I:C1838703
complex	I:C1838703
who	O
had	O
undergone	O
calcium	O
hydroxyapatite	I:C0115137
or	O
Deflux	O
injection	O
for	O
continence	O
improvement	I:C1536613
between	O
2009	O
and	O
2014	O
.	O

We	O
designed	O
a	O
retrospective	O
cohort	I:C2985505
study	I:C2985505
in	O
which	O
we	O
retrospectively	O
studied	I:C0035363
medical	O
charts	O
of	O
female	O
and	O
male	O
patients	O
of	O
bladder	O
exstrophy	I:C1838703
-	I:C1838703
epispadias	I:C1838703
complex	I:C1838703
who	O
had	O
undergone	O
calcium	B:C0115137
hydroxyapatite	I:C0115137
or	O
Deflux	O
injection	O
for	O
continence	O
improvement	I:C1536613
between	O
2009	O
and	O
2014	O
.	O

We	O
designed	O
a	O
retrospective	O
cohort	I:C2985505
study	I:C2985505
in	O
which	O
we	O
retrospectively	O
studied	I:C0035363
medical	O
charts	O
of	O
female	O
and	O
male	O
patients	O
of	O
bladder	O
exstrophy	I:C1838703
-	I:C1838703
epispadias	I:C1838703
complex	I:C1838703
who	O
had	O
undergone	O
calcium	O
hydroxyapatite	I:C0115137
or	O
Deflux	B:C0299556
injection	O
for	O
continence	O
improvement	I:C1536613
between	O
2009	O
and	O
2014	O
.	O

We	O
designed	O
a	O
retrospective	O
cohort	I:C2985505
study	I:C2985505
in	O
which	O
we	O
retrospectively	O
studied	I:C0035363
medical	O
charts	O
of	O
female	O
and	O
male	O
patients	O
of	O
bladder	O
exstrophy	I:C1838703
-	I:C1838703
epispadias	I:C1838703
complex	I:C1838703
who	O
had	O
undergone	O
calcium	O
hydroxyapatite	I:C0115137
or	O
Deflux	O
injection	B:C0021485
for	O
continence	O
improvement	I:C1536613
between	O
2009	O
and	O
2014	O
.	O

We	O
designed	O
a	O
retrospective	O
cohort	I:C2985505
study	I:C2985505
in	O
which	O
we	O
retrospectively	O
studied	I:C0035363
medical	O
charts	O
of	O
female	O
and	O
male	O
patients	O
of	O
bladder	O
exstrophy	I:C1838703
-	I:C1838703
epispadias	I:C1838703
complex	I:C1838703
who	O
had	O
undergone	O
calcium	O
hydroxyapatite	I:C0115137
or	O
Deflux	O
injection	O
for	O
continence	B:C1536613
improvement	I:C1536613
between	O
2009	O
and	O
2014	O
.	O

Sixteen	O
incontinent	B:C0021167
patients	O
with	O
a	O
mean	O
±	O
SD	O
age	O
of	O
8.09	O
±	O
3.5	O
years	O
received	O
an	O
endoscopic	O
submucosal	I:C3522839
injection	I:C3522839
of	O
5.4	O
ml	O
of	O
pure	O
calcium	O
hydroxyapatite	I:C0115137
powder	O
with	O
autologous	O
plasma	O
(	O
group	O
A	O
)	O
.	O

Sixteen	O
incontinent	O
patients	O
with	O
a	O
mean	O
±	O
SD	O
age	O
of	O
8.09	O
±	O
3.5	O
years	O
received	O
an	O
endoscopic	B:C3522839
submucosal	I:C3522839
injection	I:C3522839
of	O
5.4	O
ml	O
of	O
pure	O
calcium	O
hydroxyapatite	I:C0115137
powder	O
with	O
autologous	O
plasma	O
(	O
group	O
A	O
)	O
.	O

Sixteen	O
incontinent	O
patients	O
with	O
a	O
mean	O
±	O
SD	O
age	O
of	O
8.09	O
±	O
3.5	O
years	O
received	O
an	O
endoscopic	O
submucosal	I:C3522839
injection	I:C3522839
of	O
5.4	O
ml	O
of	O
pure	O
calcium	B:C0115137
hydroxyapatite	I:C0115137
powder	O
with	O
autologous	O
plasma	O
(	O
group	O
A	O
)	O
.	O

Sixteen	O
incontinent	O
patients	O
with	O
a	O
mean	O
±	O
SD	O
age	O
of	O
8.09	O
±	O
3.5	O
years	O
received	O
an	O
endoscopic	O
submucosal	I:C3522839
injection	I:C3522839
of	O
5.4	O
ml	O
of	O
pure	O
calcium	O
hydroxyapatite	I:C0115137
powder	O
with	O
autologous	O
plasma	B:C0032105
(	O
group	O
A	O
)	O
.	O

Patients	O
in	O
group	O
B	O
(	O
N	O
=	O
21	O
)	O
,	O
control	O
group	O
,	O
with	O
a	O
mean	O
±	O
SD	O
age	O
of	O
7.51	O
±	O
2.8	O
years	O
received	O
Deflux	B:C0299556
injection	O
(	O
5.1	O
ml	O
)	O
.	O

Patients	O
in	O
group	O
B	O
(	O
N	O
=	O
21	O
)	O
,	O
control	O
group	O
,	O
with	O
a	O
mean	O
±	O
SD	O
age	O
of	O
7.51	O
±	O
2.8	O
years	O
received	O
Deflux	O
injection	B:C0021485
(	O
5.1	O
ml	O
)	O
.	O

The	O
mean	O
follow	B:C1522577
-	I:C1522577
up	I:C1522577
after	O
injection	O
was	O
38	O
±	O
5.2	O
and	O
33	O
±	O
4.1	O
months	O
in	O
groups	O
A	O
and	O
B	O
,	O
respectively	O
.	O

The	O
mean	O
follow	O
-	I:C1522577
up	I:C1522577
after	O
injection	B:C0021485
was	O
38	O
±	O
5.2	O
and	O
33	O
±	O
4.1	O
months	O
in	O
groups	O
A	O
and	O
B	O
,	O
respectively	O
.	O

No	O
post	B:C0274425
-	I:C0274425
injection	I:C0274425
complication	I:C0274425
was	O
detected	O
in	O
none	O
of	O
the	O
patients	O
during	O
the	O
follow	O
-	I:C1522577
up	I:C1522577
.	O

No	O
post	O
-	I:C0274425
injection	I:C0274425
complication	I:C0274425
was	O
detected	B:C0442726
in	O
none	O
of	O
the	O
patients	O
during	O
the	O
follow	O
-	I:C1522577
up	I:C1522577
.	O

No	O
post	O
-	I:C0274425
injection	I:C0274425
complication	I:C0274425
was	O
detected	O
in	O
none	O
of	O
the	O
patients	O
during	O
the	O
follow	B:C1522577
-	I:C1522577
up	I:C1522577
.	O

Eleven	O
patients	O
(	O
68.75	O
%	O
)	O
in	O
group	O
A	O
became	O
socially	O
dry	O
following	O
1	O
-	O
2	O
injections	B:C0021485
,	O
the	O
degree	O
of	O
incontinence	O
was	O
improved	O
in	O
4	O
patients	O
(	O
25	O
%	O
)	O
,	O
and	O
there	O
was	O
no	O
change	I:C0442739
in	O
one	O
patient	O
(	O
6.25	O
%	O
)	O
.	O

Eleven	O
patients	O
(	O
68.75	O
%	O
)	O
in	O
group	O
A	O
became	O
socially	O
dry	O
following	O
1	O
-	O
2	O
injections	O
,	O
the	O
degree	O
of	O
incontinence	B:C0021167
was	O
improved	O
in	O
4	O
patients	O
(	O
25	O
%	O
)	O
,	O
and	O
there	O
was	O
no	O
change	I:C0442739
in	O
one	O
patient	O
(	O
6.25	O
%	O
)	O
.	O

Eleven	O
patients	O
(	O
68.75	O
%	O
)	O
in	O
group	O
A	O
became	O
socially	O
dry	O
following	O
1	O
-	O
2	O
injections	O
,	O
the	O
degree	O
of	O
incontinence	O
was	O
improved	O
in	O
4	O
patients	O
(	O
25	O
%	O
)	O
,	O
and	O
there	O
was	O
no	B:C0442739
change	I:C0442739
in	O
one	O
patient	O
(	O
6.25	O
%	O
)	O
.	O

However	O
,	O
Deflux	B:C0299556
injection	O
resulted	O
in	O
complete	O
dryness	O
in	O
14	O
(	O
66.66	O
%	O
)	O
,	O
improvement	O
in	O
the	O
degree	O
of	O
incontinence	O
in	O
5	O
(	O
23.81	O
%	O
)	O
and	O
no	O
change	I:C0442739
in	O
2	O
patients	O
(	O
9.52	O
%	O
)	O
,	O
leading	O
to	O
no	O
significant	O
difference	O
in	O
continence	O
achievement	I:C0442964
between	O
calcium	O
hydroxyapatite	I:C0115137
and	O
Deflux	O
groups	O
(	O
p	O
=	O
0.9	O
)	O
.	O

However	O
,	O
Deflux	O
injection	B:C0021485
resulted	O
in	O
complete	O
dryness	O
in	O
14	O
(	O
66.66	O
%	O
)	O
,	O
improvement	O
in	O
the	O
degree	O
of	O
incontinence	O
in	O
5	O
(	O
23.81	O
%	O
)	O
and	O
no	O
change	I:C0442739
in	O
2	O
patients	O
(	O
9.52	O
%	O
)	O
,	O
leading	O
to	O
no	O
significant	O
difference	O
in	O
continence	O
achievement	I:C0442964
between	O
calcium	O
hydroxyapatite	I:C0115137
and	O
Deflux	O
groups	O
(	O
p	O
=	O
0.9	O
)	O
.	O

However	O
,	O
Deflux	O
injection	O
resulted	O
in	O
complete	O
dryness	O
in	O
14	O
(	O
66.66	O
%	O
)	O
,	O
improvement	O
in	O
the	O
degree	O
of	O
incontinence	B:C0021167
in	O
5	O
(	O
23.81	O
%	O
)	O
and	O
no	O
change	I:C0442739
in	O
2	O
patients	O
(	O
9.52	O
%	O
)	O
,	O
leading	O
to	O
no	O
significant	O
difference	O
in	O
continence	O
achievement	I:C0442964
between	O
calcium	O
hydroxyapatite	I:C0115137
and	O
Deflux	O
groups	O
(	O
p	O
=	O
0.9	O
)	O
.	O

However	O
,	O
Deflux	O
injection	O
resulted	O
in	O
complete	O
dryness	O
in	O
14	O
(	O
66.66	O
%	O
)	O
,	O
improvement	O
in	O
the	O
degree	O
of	O
incontinence	O
in	O
5	O
(	O
23.81	O
%	O
)	O
and	O
no	B:C0442739
change	I:C0442739
in	O
2	O
patients	O
(	O
9.52	O
%	O
)	O
,	O
leading	O
to	O
no	O
significant	O
difference	O
in	O
continence	O
achievement	I:C0442964
between	O
calcium	O
hydroxyapatite	I:C0115137
and	O
Deflux	O
groups	O
(	O
p	O
=	O
0.9	O
)	O
.	O

However	O
,	O
Deflux	O
injection	O
resulted	O
in	O
complete	O
dryness	O
in	O
14	O
(	O
66.66	O
%	O
)	O
,	O
improvement	O
in	O
the	O
degree	O
of	O
incontinence	O
in	O
5	O
(	O
23.81	O
%	O
)	O
and	O
no	O
change	I:C0442739
in	O
2	O
patients	O
(	O
9.52	O
%	O
)	O
,	O
leading	O
to	O
no	O
significant	O
difference	O
in	O
continence	B:C0442964
achievement	I:C0442964
between	O
calcium	O
hydroxyapatite	I:C0115137
and	O
Deflux	O
groups	O
(	O
p	O
=	O
0.9	O
)	O
.	O

However	O
,	O
Deflux	O
injection	O
resulted	O
in	O
complete	O
dryness	O
in	O
14	O
(	O
66.66	O
%	O
)	O
,	O
improvement	O
in	O
the	O
degree	O
of	O
incontinence	O
in	O
5	O
(	O
23.81	O
%	O
)	O
and	O
no	O
change	I:C0442739
in	O
2	O
patients	O
(	O
9.52	O
%	O
)	O
,	O
leading	O
to	O
no	O
significant	O
difference	O
in	O
continence	O
achievement	I:C0442964
between	O
calcium	B:C0115137
hydroxyapatite	I:C0115137
and	O
Deflux	O
groups	O
(	O
p	O
=	O
0.9	O
)	O
.	O

However	O
,	O
Deflux	O
injection	O
resulted	O
in	O
complete	O
dryness	O
in	O
14	O
(	O
66.66	O
%	O
)	O
,	O
improvement	O
in	O
the	O
degree	O
of	O
incontinence	O
in	O
5	O
(	O
23.81	O
%	O
)	O
and	O
no	O
change	I:C0442739
in	O
2	O
patients	O
(	O
9.52	O
%	O
)	O
,	O
leading	O
to	O
no	O
significant	O
difference	O
in	O
continence	O
achievement	I:C0442964
between	O
calcium	O
hydroxyapatite	I:C0115137
and	O
Deflux	B:C0299556
groups	O
(	O
p	O
=	O
0.9	O
)	O
.	O

The	O
statistical	O
analysis	O
was	O
not	O
significantly	O
different	O
in	O
terms	O
of	O
bladder	B:C0429807
capacity	I:C0429807
(	O
p	O
=	O
0.7	O
)	O
or	O
Q	O
max	O
(	O
p	O
=	O
0.8	O
)	O
.	O

The	O
preliminary	O
results	O
of	O
this	O
study	B:C2603343
revealed	O
that	O
calcium	O
hydroxyapatite	I:C0115137
may	O
be	O
applied	O
as	O
an	O
affordable	O
bulking	O
agent	I:C1320234
in	O
treatment	O
of	O
urinary	O
incontinence	I:C0042024
in	O
bladder	O
exstrophy	I:C1838703
-	I:C1838703
epispadias	I:C1838703
complex	I:C1838703
.	O

The	O
preliminary	O
results	O
of	O
this	O
study	O
revealed	O
that	O
calcium	B:C0115137
hydroxyapatite	I:C0115137
may	O
be	O
applied	O
as	O
an	O
affordable	O
bulking	O
agent	I:C1320234
in	O
treatment	O
of	O
urinary	O
incontinence	I:C0042024
in	O
bladder	O
exstrophy	I:C1838703
-	I:C1838703
epispadias	I:C1838703
complex	I:C1838703
.	O

The	O
preliminary	O
results	O
of	O
this	O
study	O
revealed	O
that	O
calcium	O
hydroxyapatite	I:C0115137
may	O
be	O
applied	O
as	O
an	O
affordable	O
bulking	B:C1320234
agent	I:C1320234
in	O
treatment	O
of	O
urinary	O
incontinence	I:C0042024
in	O
bladder	O
exstrophy	I:C1838703
-	I:C1838703
epispadias	I:C1838703
complex	I:C1838703
.	O

The	O
preliminary	O
results	O
of	O
this	O
study	O
revealed	O
that	O
calcium	O
hydroxyapatite	I:C0115137
may	O
be	O
applied	O
as	O
an	O
affordable	O
bulking	O
agent	I:C1320234
in	O
treatment	B:C0087111
of	O
urinary	O
incontinence	I:C0042024
in	O
bladder	O
exstrophy	I:C1838703
-	I:C1838703
epispadias	I:C1838703
complex	I:C1838703
.	O

The	O
preliminary	O
results	O
of	O
this	O
study	O
revealed	O
that	O
calcium	O
hydroxyapatite	I:C0115137
may	O
be	O
applied	O
as	O
an	O
affordable	O
bulking	O
agent	I:C1320234
in	O
treatment	O
of	O
urinary	B:C0042024
incontinence	I:C0042024
in	O
bladder	O
exstrophy	I:C1838703
-	I:C1838703
epispadias	I:C1838703
complex	I:C1838703
.	O

The	O
preliminary	O
results	O
of	O
this	O
study	O
revealed	O
that	O
calcium	O
hydroxyapatite	I:C0115137
may	O
be	O
applied	O
as	O
an	O
affordable	O
bulking	O
agent	I:C1320234
in	O
treatment	O
of	O
urinary	O
incontinence	I:C0042024
in	O
bladder	B:C1838703
exstrophy	I:C1838703
-	I:C1838703
epispadias	I:C1838703
complex	I:C1838703
.	O

